Breaking News

FDA Extends GVK Biomarker Database License

Will be used for biomarker qualification process

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GVK Biosciences is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the U.S. FDA. The GOBIOM database has the latest and recently updated information on all biomarkers reported in various clinical and preclinical studies and will be used by the FDA in its biomarker qualification process.   GOBIOM contains information on 20,000 biomarkers comprising biochemical, genomic, imaging, metabolite, cellular and physiological markers, as well as multiple ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters